SCLC-N (NEUROD1-dominant): Defined by predominant expression of Neurogenic Differentiation Factor 1 (NEUROD1), this subtype exhibits features of neuronal differentiation and often harbors MYC gene amplifications, suggesting potential vulnerability to aurora kinase inhibitors and other MYC-targeted therapies. The gene discussed is MYC; the disease is small cell lung carcinoma.